Real-world treatment patterns and outcomes of patients with advanced melanoma treated with nivolumab plus relatimab

被引：0
|
作者：
Thakker, Sach
Belzberg, Micah
Stahl, Chelsea
Jang, Sekwon
Al-Mondhiry, Jafar
机构：
[1] Georgetown Univ, Sch Med, Washington, DC USA
[2] Johns Hopkins Univ, Dept Dermatol, Sch Med, Baltimore, MD USA
[3] Inova Schar Canc Inst, Fairfax, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21501
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-world treatment patterns and outcomes among patients with BRAF plus metastatic melanoma refractory to first-line immunotherapy
    Truong, T. G.
    Chandra, S.
    Connolly, L.
    Shah, R.
    Byrne, C.
    Tang, J.
    Eroglu, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S673 - S673
  • [32] Outcomes in patients with resected stage IIIA melanoma treated with adjuvant nivolumab or monitored with observation: A real-world study.
    Pavlick, Anna C.
    Amin, Asim
    Moser, Justin C.
    Poretta, Tayla
    Sakkal, Leon Alan
    Moshyk, Andriy
    Klink, Andrew J.
    Schuler, Tammy
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [33] Real-world treatment patterns and outcomes for patients with advanced hepatocellular carcinoma initially treated with PD-1 inhibitors
    Zou, Huimin
    Ge, Ying
    Chen, Wenge
    Yao, Dongning
    Ung, Carolina Oi Lam
    Lai, Yunfeng
    Hu, Hao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 132
  • [34] Real-world data on nivolumab treatment in Asian patients with advanced hepatocellular carcinoma
    Yoon, S. E.
    Hur, J. Y.
    Lee, K. K.
    Lee, S. J.
    Lee, J.
    Paik, S. W.
    Lim, H. Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Real-world outcomes in patients with metastatic renal cell carcinoma treated with first-line nivolumab plus ipilimumab
    Doshi, Gurjyot K.
    Robert, Nicholas J.
    Chen, Liwei
    Chan, Philip K.
    Del Tejo, Viviana
    Stwalley, Brian
    Huo, Stephen
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28)
  • [36] Real-World Treatment Patterns and Effectiveness in Patients with ALK plus Advanced NSCLC Treated with 1L ALK TKIs
    Chen, Y.
    Lin, H. M.
    Wan, Y.
    Yin, Y.
    Wu, Y.
    Hernandez, L.
    Danes, C.
    Churchill, E. N.
    Dimou, A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S641 - S641
  • [37] Real-world survival of advanced melanoma patients treated with immunotherapy and targeted therapy
    Yu, Su-Yeon
    McKavanagh, Dan
    McPherson, Ian
    Walpole, Euan
    Hollingworth, Samantha
    Atkinson, Victoria
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 177 - 177
  • [38] Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma
    Asher, Nethanel
    Ben-Betzalel, Guy
    Lev-Ari, Shaked
    Shapira-Frommer, Ronnie
    Steinberg-Silman, Yael
    Gochman, Neta
    Schachter, Jacob
    Meirson, Tomer
    Markel, Gal
    CANCERS, 2020, 12 (08) : 1 - 18
  • [39] A real world retrospective study of advanced gastric cancer patients treated with nivolumab plus chemotherapy
    Komoda, M.
    Okumura, Y.
    Arimizu, K.
    Matsumura, T.
    Nishijima, T.
    Esaki, T.
    ANNALS OF ONCOLOGY, 2024, 35 : S1370 - S1370
  • [40] Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study
    McDaniel, Brandon T.
    Cornet, Victor
    Carroll, Jeanne
    Chrones, Lambros
    Chudzik, Joseph
    Cochran, Jeanette
    Guha, Shion
    Lawrence, Debra F.
    McCue, Maggie
    Sarkey, Sara
    Lorenz, Betty
    Fawver, Jay
    BMC PSYCHIATRY, 2023, 23 (01)
12345